An EGFR‐targeting antibody–drug conjugate LR004‐VC‐MMAE: potential in esophageal squamous cell carcinoma and other malignancies

Epidermal growth factor receptor (EGFR) is a rational target for cancer therapy, because its overexpression plays an important oncogenic role in a variety of solid tumors; however, EGFR‐targeted antibody–drug conjugate (ADC) therapy for esophageal squamous cell carcinoma (ESCC) is exceedingly rare....

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xin‐yue, Wang, Rong, Jin, Jie, Liu, Xiu‐jun, Cui, A‐long, Sun, Lian‐qi, Li, Yan‐ping, Li, Yi, Wang, Yu‐cheng, Zhen, Yong‐su, Miao, Qing‐fang, Li, Zhuo‐rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360372/
https://www.ncbi.nlm.nih.gov/pubmed/30372581
http://dx.doi.org/10.1002/1878-0261.12400

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6360372/
https://www.ncbi.nlm.nih.gov/pubmed/30372581
http://dx.doi.org/10.1002/1878-0261.12400

Ejemplares similares